Navigation Links
Fairer sex Has A Better Chance Of Surviving Lung Cancer

A new study presented at the 71st annual international scientific assembly of the American College of Chest Physicians (ACCP), CHEST 2005, says that women have a better chance of surviving lung cancer than men even without treatment.//

The study also found that in untreated patients women had a 21 percent decreased chance of succumbing to the cancer than men. These findings have led researchers to theorize that lung cancer in women has a different biological behavioral pattern than in men.

In the current study, researchers from Mount Sinai School of Medicine 18,967 patients with stage I and II non-small cell lung cancer diagnosed from 1991 and 1999 from the Surveillance, Epidemiology, and End Results registry linked to Medicare records. They divided patients into four groups based on the treatment received into surgery, radiation or chemotherapy, and untreated cases.

They found that women in all the groups had better cancer specific, overall, and relative survival rates than men. Women had a 54 percent chance of surviving five years after treatment as compared to 40 percent in men. When factors such as age, race, disease stage at diagnosis, histology, median income, geographic area, access to care, and type of treatment were taken into consideration, the researchers found that women lived longer than men.

New data suggest that even in untreated patients, women with lung cancer still live longer than men, despite the presence of other medical conditions or gender differences in life expectancy. This suggests that the progression of lung cancer has a biological basis, with the disease being more aggressive in men than women, said Juan Wisnivesky, MD, MPH, FCCP, Mount Sinai School of Medicine, New York, NY.
'"/>




Page: 1

Related medicine news :

1. Fairer Sex Better Equipped To Deal With Heart Disease
2. Better prostate cancer detection
3. Better Treatment for obesity
4. For a Better Memory
5. Baby Talk Better Than Adult Speech
6. Drug Combo Works Better for children with ADHD, Tics
7. Better skin with lasers
8. Better diabetes treatment promises Vanadium
9. Better Prostate Cancer Test
10. Better Drug for Heart Transplant
11. Better Diet Even Late in Life May Prolong It
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... , ... January 19, 2017 , ... ... by the American Board of Dermatology and fellowship trained Mohs and cosmetic surgeon. ... Institutes of Health, Dr. Li completed his internship in internal medicine at the ...
(Date:1/19/2017)... ... January 19, 2017 , ... In 2009, Carol ... that resulted in severe facial disfiguration. After four frightening years of isolation and ... UCLA Medical Center, who removed the substances in a partial facial transplant through ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... and privacy panel system. , The Tranquility privacy panel system was designed ... office environment. Tranquility panels help reduce noise and provide the visual privacy required ...
(Date:1/19/2017)... ... , ... Sam & Associates Insurance Agency, a full service firm providing asset ... Bay Area, is launching a charity drive to raise awareness of heart disease risk ... primary killer of adult men and women in America, and is responsible for over ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... agency which serves Lawrenceville, New Jersey and the surrounding area, is inaugurating ... lateral sclerosis (ALS), more commonly known as Lou Gehrig's disease or motor neurone ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017 The Philadelphia Pediatric Medical ... developing medical devices for children. The Consortium chose ... seed grants of $50,000 each. The devices under ... nerve signals, a hand-operated rapid blood delivery system for emergency ... babies. ...
(Date:1/18/2017)...   Regenicin, Inc. (OTC Bulletin Board: ... development and commercialization of regenerative cell therapies to restore ... the Company,s operating results for 2016 and an outline ... Company described in its recent 10-K filing with the ... The Company,s contract laboratory completed its evaluation of NovaDerm┬«, ...
(Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
Breaking Medicine Technology: